Podcast
Hear the podcastG. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
See all News
Anton Gueth
Managing DirectorMr. Gueth began his management career in business and alliance development over 20 years ago at Eli Lilly and Company. His global experience spans the U.S., Europe, the Middle East and Africa. Before joining Burrill & Company, Mr. Gueth was an independent consultant for pharmaceutical and biotechnology clients in the areas of licensing, early-stage financing and alliance management. His clients included Baxter, Amgen, Boehringer Ingelheim, Schering-Plough and Schering AG, among others. While at Lilly, Mr. Gueth held multiple positions of increasing responsibility, concluding as Director of Alliance Management. In this role he led Lilly’s efforts to become “the pharmaceutical partner of choice”. Mr. Gueth is a member of the board of directors of Antares Pharma. He is also on the board of the California chapter of the American Liver Foundation. An author and lecturer, Mr. Gueth has contributed to industry reports from In Vivo and Ernst and Young as well as business texts on strategic alliances. Mr. Gueth received his master’s degree in public affairs from Indiana University and an M.S. in agricultural economics from Justus Liebig University in Germany.



